{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:12:26Z","timestamp":1778778746117,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014835","name":"Istituto Nazionale Tumori IRCCS Fondazione Pascale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["LINEA 4\/15_25"],"award-info":[{"award-number":["LINEA 4\/15_25"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clon.2026.104084","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:29:39Z","timestamp":1771054179000},"page":"104084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and Safety Outcomes of Stereotactic Radiotherapy With Cyberknife System in Brain Metastases Patients Treated With Immunotherapy or Targeted Therapy"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6918-2178","authenticated-orcid":false,"given":"R.","family":"Di Franco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6676-1169","authenticated-orcid":false,"given":"D.","family":"Pezzulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Borzillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3896-0392","authenticated-orcid":false,"given":"E.","family":"Scipilliti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3089-6141","authenticated-orcid":false,"given":"S.","family":"Mercogliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Cilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sandomenico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Viggiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ametrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1694-5857","authenticated-orcid":false,"given":"F.","family":"Buonanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8756-5498","authenticated-orcid":false,"given":"C.","family":"Arrichiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"d'Alesio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0529-201X","authenticated-orcid":false,"given":"G.","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1276-5070","authenticated-orcid":false,"given":"F.","family":"Deodato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Ravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clon.2026.104084_bib1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","article-title":"Epidemiology of brain metastases and leptomeningeal disease","volume":"23","author":"Lamba","year":"2021","journal-title":"Neuro-Oncol"},{"issue":"11","key":"10.1016\/j.clon.2026.104084_bib2","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro-Oncol"},{"issue":"9","key":"10.1016\/j.clon.2026.104084_bib3","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/neuonc\/nos152","article-title":"Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data","volume":"14","author":"Davis","year":"2012","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.clon.2026.104084_bib4","series-title":"Treatment plan comparison for irradiation of multiple brain metastases with hippocampal avoidance whole brain radiotherapy and simultaneous integrated boost using the Varian Halcyon and the Elekta Synergy platforms Research Open access Published","author":"Kraft","year":"2022"},{"issue":"15","key":"10.1016\/j.clon.2026.104084_bib5","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.3390\/cancers13153682","article-title":"Integration of systemic therapy and stereotactic radiosurgery for brain metastases","volume":"13","author":"Tonse","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clon.2026.104084_bib6","article-title":"Control and toxicity in melanoma versus other brain metastases in response to combined radiosurgery and PD-(L)1 immune checkpoint inhibition","volume":"6","author":"Travis","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"10.1016\/j.clon.2026.104084_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.semradonc.2021.02.001","article-title":"Mechanisms of Immune Modulation by Radiation","volume":"31","author":"Spina","year":"2021","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.clon.2026.104084_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood-2009-02-206870","article-title":"Therapeutic effects of ablative radiation on local tumor require CD8+ T cells:changing strategies for cancer treatment","volume":"114","author":"Lee","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clon.2026.104084_bib9","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1172\/JCI41911","article-title":"Tracking of immune cells in the central nervous system","volume":"120","author":"Wilson","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clon.2026.104084_bib10","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.adro.2017.07.003","article-title":"Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents","volume":"2","author":"Acharya","year":"2017","journal-title":"Adv Rad Oncol"},{"key":"10.1016\/j.clon.2026.104084_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104227","article-title":"Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review","volume":"194","author":"Li","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clon.2026.104084_bib12","article-title":"Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis","volume":"39","author":"Bodensohn","year":"2023","journal-title":"Clin Transl Rad Oncol"},{"issue":"1","key":"10.1016\/j.clon.2026.104084_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13014-020-1485-8","article-title":"Stereotactic radiosurgery combined with targeted\/immunotherapy in patients with melanoma brain metastasis","volume":"15","author":"Hadi","year":"2020","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.clon.2026.104084_bib14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/1754-9485.13403","article-title":"Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes","volume":"66","author":"Shanker","year":"2022","journal-title":"J Med Imag Rad Oncol"},{"issue":"3","key":"10.1016\/j.clon.2026.104084_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/neuonc\/noab262","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO Guideline","volume":"331 24","author":"Vogelbaum","year":"2022","journal-title":"Neuro-Oncol"},{"issue":"1","key":"10.1016\/j.clon.2026.104084_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1227\/NEU.0000000000000190","article-title":"The volumetric response of brain metastases after stereotactic radiosurgery and its post-treatment implications","volume":"74","author":"Sharpton","year":"2014","journal-title":"Neurosurgery"},{"key":"10.1016\/j.clon.2026.104084_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00184","article-title":"Efficacy and tolerance of post-operative hypo-fractionated stereotactic radiotherapy in a large series of patients with brain metastases","author":"Martinage","year":"2019","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.clon.2026.104084_bib18","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/neuonc\/noab129","article-title":"Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO","volume":"23","author":"Scoccianti","year":"2021","journal-title":"Neuro-Oncol"},{"issue":"1","key":"10.1016\/j.clon.2026.104084_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","article-title":"Single and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain","volume":"110","author":"Milano","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.clon.2026.104084_bib20","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3390\/cancers13081857","article-title":"Ipilimumab and stereotactic radiosurgery with CyberKnife\u00ae system in melanoma brain metastases: a retrospective Mono institutional experience","volume":"13","author":"Borzillo","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.clon.2026.104084_bib21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/pcmr.12775","article-title":"Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies","volume":"32","author":"Pires da Silva","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.clon.2026.104084_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3171\/2018.10.JNS182340","article-title":"Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases","volume":"132","author":"Parsai","year":"2019","journal-title":"J Neurosurg"},{"key":"10.1016\/j.clon.2026.104084_bib23","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/S1470-2045(22)00752-5","article-title":"Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC\u2013ESTRO OligoCare consortium -","volume":"24","author":"Kroeze","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2026.104084_bib24","series-title":"Common Terminology Criteria for Adverse Events (CTCAE)","year":"2017"},{"issue":"2","key":"10.1016\/j.clon.2026.104084_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"}],"updated-by":[{"DOI":"10.1016\/j.clon.2026.104161","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000}}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526000555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526000555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:25:31Z","timestamp":1778775931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655526000555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":25,"alternative-id":["S0936655526000555"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2026.104084","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety Outcomes of Stereotactic Radiotherapy With Cyberknife System in Brain Metastases Patients Treated With Immunotherapy or Targeted Therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2026.104084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"104084"}}